Emerging therapies in allergic conjunctivitis and dry eye syndrome

New Directions in Immunotherapy

(2013) Linda Cox et al.   CURRENT ALLERGY AND ASTHMA REPORTS

Delivery Systems and Local Administration Routes for Therapeutic siRNA

(2013) Fabiana Testa Moura de Carvalho Vicentini et al.   PHARMACEUTICAL RESEARCH

A Phase 2 Randomized, Double-Masked, Placebo-Controlled Study of a Novel Integrin Antagonist (SAR 1118) for the Treatment of Dry Eye

(2012) Charles P. Semba et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Allergic conjunctivitis and dry eye syndrome

(2012) Milton M. Hom et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Dry Eye Disease

(2012) William Stevenson   ARCHIVES OF OPHTHALMOLOGY

Resolvins as new fascinating drug candidates for inflammatory diseases

(2012) Chang Hoon Lee   ARCHIVES OF PHARMACAL RESEARCH

Vernal keratoconjunctivitis: an update

(2012) Stefan De Smedt et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: The importance of allergen-specific serum IgE

(2012) Linda S. Cox et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Development of Sustained-Release Microspheres for the Delivery of SAR 1118, an LFA-1 Antagonist Intended for the Treatment of Vascular Complications of the Eye

(2012) Sarath Yandrapu et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Rebamipide (OPC-12759) in the Treatment of Dry Eye: A Randomized, Double-Masked, Multicenter, Placebo-Controlled Phase II Study

(2012) Shigeru Kinoshita et al.   OPHTHALMOLOGY

Management of seasonal allergic conjunctivitis: guide to therapy

(2011) Brett P. Bielory et al.   ACTA OPHTHALMOLOGICA

Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study

(2011) L. Klimek et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications

(2011) Allan L Goldstein et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults

(2011) Harold S. Nelson et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Conjunctival Goblet Cell Secretion Stimulated by Leukotrienes Is Reduced by Resolvins D1 and E1 To Promote Resolution of Inflammation

(2011) Darlene A. Dartt et al.   JOURNAL OF IMMUNOLOGY

Beneficial Pharmacological Effects of Selective Glucocorticoid Receptor Agonist in External Eye Diseases

(2011) Masatomo Kato et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Maps and legends: The quest for dissociated ligands of the glucocorticoid receptor

(2011) Andrew R. Clark et al.   PHARMACOLOGY & THERAPEUTICS

Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results

(2010) Robert E. Esch et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Targeting inflammation using selective glucocorticoid receptor modulators

(2010) Karolien De Bosscher et al.   CURRENT OPINION IN PHARMACOLOGY

Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen

(2010) David Skoner et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The epidemiology of ocular and nasal allergy in the United States, 1988-1994

(2010) Kavita Singh et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Allergen-specific immunotherapy for respiratory allergies: From meta-analysis to registration and beyond

(2010) Moisés A. Calderón et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Efficacy in Patients with Dry Eye After Treatment with a New Lubricant Eye Drop Formulation

(2010) William F. Davitt et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Safety and Pharmacokinetics of a Novel Lymphocyte Function-associated Antigen-1 Antagonist Ophthalmic Solution (SAR 1118) in Healthy Adults

(2010) Charles P. Semba et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study

(2009) P. Kuna et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Tear fluid concentration of mmp–8 is elevated in non—allergic eosinophilic conjunctivitis and correlates with conjunctival inflammatory cell infiltration

(2009) Osmo Kari et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Évaluation de l’efficacité du NAAGA dans la sécheresse oculaire

(2009) F. Brignole-Baudouin et al.   JOURNAL FRANCAIS D OPHTALMOLOGIE

A Large Prospective Observational Study of Novel Cyclosporine 0.1% Aqueous Ophthalmic Solution in the Treatment of Severe Allergic Conjunctivitis

(2009) Nobuyuki Ebihara et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis

(2009) Matthew Spite et al.   NATURE

Comparison of the efficacy and safety of bilastine 20 mgvsdesloratadine 5 mg in seasonal allergic rhinitis patients

(2008) C. Bachert et al.   ALLERGY

Allergic Conjunctivitis

(2008) Leonard Bielory et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Vernal Conjunctivitis

(2008) Jason Jun et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Giant Papillary Conjunctivitis

(2008) Peter C. Donshik et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial

(2008) G. Senti et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA